Liberty Biopharma Inc (CVE:LTY – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Trading Up ∞
The firm has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a quick ratio of 0.12, a current ratio of 0.12 and a debt-to-equity ratio of 8.19. The firm’s 50 day moving average is C$2.00 and its 200 day moving average is C$2.00.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Further Reading
- Five stocks we like better than Liberty Biopharma
- 3 Under-the-Radar Defense Stocks With Record Backlogs
- This Korea ETF Has Soared, But the Rally May Not Be Over
- Why Guidewire’s Post-Earnings Plunge May Not Last
- Ride-Share Reckoning: Tesla Drives Into Uber’s Lane
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
